Patient-Centric ADT Intensification in Hormone-Sensitive Prostate Cancer: Balancing Efficacy, Safety, Quality of Life, and Survival 

This education will help clinicians develop evidence-based and collaborative treatment plans for the management of hormone-sensitive prostate cancer (HSPC) with ADT intensification, leading to improved outcomes, reduced risk of disease progression, and enhanced overall survival for individuals with HSPC.